TEBENTAFUSP for Uveal melanoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 33 adverse event reports in the FDA FAERS database where TEBENTAFUSP was used for Uveal melanoma.
Most Reported Side Effects for TEBENTAFUSP
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Cytokine release syndrome | 35 | 35.7% | 12 | 22 |
| Pyrexia | 19 | 19.4% | 7 | 13 |
| Malignant neoplasm progression | 18 | 18.4% | 4 | 7 |
| Disease progression | 11 | 11.2% | 11 | 1 |
| Pruritus | 10 | 10.2% | 4 | 3 |
| Rash | 9 | 9.2% | 2 | 6 |
| Chills | 8 | 8.2% | 4 | 4 |
| Hypotension | 8 | 8.2% | 5 | 7 |
| Death | 7 | 7.1% | 7 | 0 |
| Vomiting | 7 | 7.1% | 5 | 5 |
| Diarrhoea | 5 | 5.1% | 3 | 4 |
| Fatigue | 5 | 5.1% | 0 | 5 |
| Oxygen saturation decreased | 5 | 5.1% | 3 | 4 |
Other Indications for TEBENTAFUSP
Product used for unknown indication (21)
Metastatic ocular melanoma (15)
Malignant melanoma (13)
Choroid melanoma (8)
Other Drugs Used for Uveal melanoma
TEBENTAFUSP-TEBN (72)
NIVOLUMAB (67)
IPILIMUMAB (51)
PEMBROLIZUMAB (30)
MELPHALAN (21)
DAROVASERTIB (18)
CRIZOTINIB (16)
LENVATINIB (11)
BEVACIZUMAB (9)
TALIMOGENE LAHERPAREPVEC (9)